Pregled bibliografske jedinice broj: 674651
Stem cell transplantation for multiple myeloma in Croatia: Evaluation of the efficacy of double stem cell transplantation
Stem cell transplantation for multiple myeloma in Croatia: Evaluation of the efficacy of double stem cell transplantation // Leukemia and Lymphoma, East and West Together / Leukemia Research Vol.31 Supplement 2
Dubrovnik, Hrvatska, 2007. str. 20-21 doi:10.1016/S0145-2126(07)70275-8 (predavanje, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 674651 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Stem cell transplantation for multiple myeloma in
Croatia: Evaluation of the efficacy of double stem
cell transplantation
Autori
Nemet, Damir ; Sertić, Dubravka ; Mrsić, Mirando ; Bojanić, Ines ; Batinić, Drago ; Duraković, Nadira ; Golubić Ćepulić, Branka ; Serventi Serth, Ranka ; Radman, Ivo ; Aurer, Igor ; Zupančić Šalek, Silva ; Labar, Boris
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Leukemia and Lymphoma, East and West Together / Leukemia Research Vol.31 Supplement 2
/ - , 2007, 20-21
Skup
Leukemia and Lymphoma, East and West Together
Mjesto i datum
Dubrovnik, Hrvatska, 15.09.2007. - 19.09.2007
Vrsta sudjelovanja
Predavanje
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
Multiple myeloma ; stem cell transplantation
Sažetak
Clinical trials so far have shown that high-dose therapy and autologous hematopoietic stem cell transplantation (ASCT) improves response rates, disease-free survival (DSF), and overall survival (OS) in symptomatic patients with multiple myeloma (MM) younger than 65 years. In addition, transplant related mortality is relatively low. However, the vast majority of patients eventually develop progressive disease with the median time to relapse of approximately 3 years. Recent nonrandomized and randomized studies indicate survival benefit for multiple myeloma patients treated with double ASCT as compared to single transplant. We conducted a prospective trial of two successive high-dose chemo- or chemoradiotherapy followed by peripheral blood stem cell rescue for patients with advanced stage multiple myeloma. The aim of the study was to evaluate feasibility, efficacy, and toxicity of this treatment approach.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
MZOS-108-1081872-2061 - LIMFOPROLIFERATIVNE BOLESTI I TRANSPLANTACIJA KRVOTVORNIH MATIČNIH STANICA (Nemet, Damir, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb
Profili:
Branka Golubić Ćepulić
(autor)
Mirando Mrsić
(autor)
Dubravka Sertić
(autor)
Drago Batinić
(autor)
Boris Labar
(autor)
Igor Aurer
(autor)
Ines Bojanić
(autor)
Damir Nemet
(autor)
Silva Zupančić-Šalek
(autor)
Nadira Duraković
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE